Skip to main content
Top
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Research

Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study

Authors: Tracy Trupka, Kristen Fisher, Scott T. Micek, Paul Juang, Marin H. Kollef

Published in: Critical Care | Issue 1/2017

Login to get access

Abstract

Background

Antibiotics are commonly administered to hospitalized patients with infiltrates for possible bacterial pneumonia, often leading to unnecessary treatment and increasing the risk for resistance emergence. Therefore, we performed a study to determine if an enhanced antibiotic de-escalation practice could improve antibiotic utilization in mechanically ventilated patients with suspected pneumonia cared for in an academic closed intensive care unit (ICU).

Methods

This was a prospective cross-over trial comparing routine antibiotic management (RAM) and enhanced antimicrobial de-escalation (EAD) performed within two medical ICUs (total 34 beds) at Barnes-Jewish Hospital, an academic referral center. Patients in the EAD group had their antibiotic orders and microbiology results reviewed daily by a dedicated team comprised of a second-year critical care fellow, an ICU attending physician and an ICU pharmacist. Antibiotic de-escalation recommendations were made when appropriate based on microbiologic test results and clinical response to therapy.

Results

There were 283 patients evaluable, with suspected pneumonia requiring mechanical ventilation: 139 (49.1%) patients in the RAM group and 144 (50.9%) in the EAD group. Early treatment failure based on clinical deterioration occurred in 33 (23.7%) and 40 (27.8%) patients, respectively (P = 0.438). In the remaining patients, antimicrobial de-escalation occurred in 70 (66.0%) and 70 (67.3%), respectively (P = 0.845). There was no difference between groups in total antibiotic days ((median (interquartile range)) 7.0 days (4.0, 9.0) versus 7.0 days (4.0, 8.8) (P = 0.616)); hospital mortality (25.2% versus 35.4% (P = 0.061)); or hospital duration (12.0 days (6.0, 20.0) versus 11.0 days (6.0, 22.0) (P = 0.918).

Conclusions

The addition of an EAD program to a high-intensity daytime staffing model already practicing a high-level of antibiotic stewardship in an academic ICU was not associated with greater antibiotic de-escalation or a reduction in the overall duration of antibiotic therapy.

Trial registration

ClinicalTrials.gov, NCT02685930. Registered on 26 January 2016.
Appendix
Available only for authorised users
Literature
1.
go back to reference Thaden JT, Li Y, Ruffin F, Maskarinec SA, et al. Increased costs with multidrug resistant Gram negative bloodstream infections are primarily due to patients with hospital-acquired infections. Antimicrob Agents Chemother. 2017;61i:e01709–16. Thaden JT, Li Y, Ruffin F, Maskarinec SA, et al. Increased costs with multidrug resistant Gram negative bloodstream infections are primarily due to patients with hospital-acquired infections. Antimicrob Agents Chemother. 2017;61i:e01709–16.
2.
go back to reference Rojas LJ, Salim M, Cober E, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64:711–8.PubMed Rojas LJ, Salim M, Cober E, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64:711–8.PubMed
3.
go back to reference Righi E, Peri AM, Harris PN, et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72:668–77.PubMed Righi E, Peri AM, Harris PN, et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72:668–77.PubMed
4.
5.
go back to reference Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;20:45.CrossRef Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;20:45.CrossRef
6.
go back to reference Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.CrossRefPubMed
7.
go back to reference Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.CrossRefPubMed Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.CrossRefPubMed
8.
go back to reference Hansen V, Oren E, Dennis LK, Brown HE. Infectious disease mortality trends in the United States, 1980-2014. JAMA. 2016;316:2149–51.CrossRefPubMed Hansen V, Oren E, Dennis LK, Brown HE. Infectious disease mortality trends in the United States, 1980-2014. JAMA. 2016;316:2149–51.CrossRefPubMed
10.
go back to reference Daniel Markley J, Bernard S, Bearman G, Stevens MP. De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges. Curr Infect Dis Rep. 2017;19:17.CrossRefPubMed Daniel Markley J, Bernard S, Bearman G, Stevens MP. De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges. Curr Infect Dis Rep. 2017;19:17.CrossRefPubMed
11.
go back to reference American Thoracic Society. Infectious Diseases Society of America: guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.CrossRef American Thoracic Society. Infectious Diseases Society of America: guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.CrossRef
12.
13.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed
15.
go back to reference Tabah A, Cotta MO, Garnacho-Montero J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the Intensive Care Unit. Clin Infect Dis. 2016;62:1009–17.CrossRefPubMed Tabah A, Cotta MO, Garnacho-Montero J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the Intensive Care Unit. Clin Infect Dis. 2016;62:1009–17.CrossRefPubMed
16.
go back to reference Kollef MH, Burnham CA. Ventilator-associated pneumonia: the role of emerging diagnostic technologies. Seminar Respir Crit Care Med. 2017. [In Press] Kollef MH, Burnham CA. Ventilator-associated pneumonia: the role of emerging diagnostic technologies. Seminar Respir Crit Care Med. 2017. [In Press]
17.
go back to reference Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017; doi:10.1007/s00134-017-4682-7. [Epub ahead of print]. Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017; doi:10.​1007/​s00134-017-4682-7. [Epub ahead of print].
18.
go back to reference Vincent JL, Brealey D, Libert N, et al. Rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit Care Med. 2015;43:2283–91.CrossRefPubMedPubMedCentral Vincent JL, Brealey D, Libert N, et al. Rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit Care Med. 2015;43:2283–91.CrossRefPubMedPubMedCentral
19.
go back to reference Tedeschi S, Trapani F, Giannella M, et al. An antimicrobial stewardship program based on systematic infectious disease consultation in a rehabilitation facility. Infect Control Hosp Epidemiol. 2017;38:76–82.CrossRefPubMed Tedeschi S, Trapani F, Giannella M, et al. An antimicrobial stewardship program based on systematic infectious disease consultation in a rehabilitation facility. Infect Control Hosp Epidemiol. 2017;38:76–82.CrossRefPubMed
20.
go back to reference Pulcini C, Botelho-Nevers E, Dyar OJ, Harbarth S. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect. 2014;20:963–72.CrossRefPubMed Pulcini C, Botelho-Nevers E, Dyar OJ, Harbarth S. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect. 2014;20:963–72.CrossRefPubMed
21.
go back to reference Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125:1791–9.CrossRefPubMed Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125:1791–9.CrossRefPubMed
22.
go back to reference Crotty MP, Meyers S, Hampton N, et al. Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Crit Care. 2015;1(9):404.CrossRef Crotty MP, Meyers S, Hampton N, et al. Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Crit Care. 2015;1(9):404.CrossRef
23.
go back to reference Arnold HM, Hollands JM, Skrupky LP, et al. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Ann Pharmacother. 2013;47:170–80.CrossRefPubMed Arnold HM, Hollands JM, Skrupky LP, et al. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Ann Pharmacother. 2013;47:170–80.CrossRefPubMed
24.
go back to reference Wallace DJ, Angus DC, Barnato AE, Kramer AA, Kahn JM. Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med. 2012;366:2093–101.CrossRefPubMedPubMedCentral Wallace DJ, Angus DC, Barnato AE, Kramer AA, Kahn JM. Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med. 2012;366:2093–101.CrossRefPubMedPubMedCentral
25.
go back to reference Nolley EP, Trevino SE, Babcock HM, Kollef MH. A targeted educational intervention to reduce ventilator-associated complications. Am J Infect Control. 2016;44:1406–7.CrossRefPubMed Nolley EP, Trevino SE, Babcock HM, Kollef MH. A targeted educational intervention to reduce ventilator-associated complications. Am J Infect Control. 2016;44:1406–7.CrossRefPubMed
Metadata
Title
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study
Authors
Tracy Trupka
Kristen Fisher
Scott T. Micek
Paul Juang
Marin H. Kollef
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-017-1772-4

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue